期刊名称：General Internal Medicine and Clinical Innovations
电子版ISSN：2397-5237
出版年度：2018
卷号：3
期号：3
页码：1-2
DOI：10.15761-GIMCI.1000164
语种：English
出版社：Open Access Text
摘要：White coat hypertension (WCH) was presented first time by Pickering in1988 and is characterized by elevated office BP but normal reading when measured outside the office with either ABPM or HBPM [1]. The prevalence of WCH is from 13% to 35% in different populations [2,3]. Although most studies have shown scarcely difference of all-cause mortality or CVD risks between WCH and normotensive people [4], WCH patients have a 1.5–2.0-fold higher risk of developing sustained hypertension than normotensive controls after 10 years [5], especially for those people who are older, obesity, or black race [3,6]. Obstructive sleep apnea (OSA) is characterized by recurrent collapse of the upper airways during sleep, inducing intermittent episodes of apnea/hypopnea, hypoxemia, and sleep disruption [7], and is one of the risk factors for cardiovascular diseases, such as hypertension, coronary heart disease and cerebrovascular diseases, heart failure and atrial fibrillation [8]. Studies demonstrated that hypertension highly prevalent in OSA, and the presence of OSA is associated with an increased incident of resistant hypertension [9,10].
